Vitamin D deficiency and graft-versus-host disease in hematopoietic stem cell transplant population | Zendy

Abeer Arain | Zendy; Chance Matthiesen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Vitamin D deficiency and graft-versus-host disease in hematopoietic stem cell transplant population

Author(s) -

Abeer Arain,

Chance Matthiesen

Publication year - 2018

Publication title -

hematology/oncology and stem cell therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.666

H-Index - 22

eISSN - 1658-3876

pISSN - 2589-0646

DOI - 10.1016/j.hemonc.2018.08.001

Subject(s) - immune system , vitamin d and neurology , graft versus host disease , stem cell , immunology , disease , hematopoietic stem cell transplantation , haematopoiesis , vitamin , vitamin d deficiency , transplantation , hemostasis , medicine , population , biology , endocrinology , microbiology and biotechnology , environmental health

Vitamins are the organic compounds that have long been known to play a significant role in our body by functioning as hormones and antioxidants. Vitamin D, a fat-soluble vitamin, is the main regulator of calcium hemostasis in our body. At the same time, it is also known to show its potential effects on the immune system by modulating the differentiation, activation, and proliferation of T and B lymphocytes. The immunomodulatory properties of vitamin D are also known to have a crucial role in the prevention and treatment of graft-versus-host disease. Patients undergoing hematopoietic stem cell transplantation are particularly at risk of vitamin D deficiency. This review article expands our understanding of vitamin D, its immunomodulatory effects, and its role in prevention and treatment of graft-versus-host disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research